271 related articles for article (PubMed ID: 9458212)
1. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.
Partsch G; Wagner E; Leeb BF; Dunky A; Steiner G; Smolen JS
J Rheumatol; 1998 Jan; 25(1):105-10. PubMed ID: 9458212
[TBL] [Abstract][Full Text] [Related]
2. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
3. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
[TBL] [Abstract][Full Text] [Related]
4. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
[TBL] [Abstract][Full Text] [Related]
5. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid.
Partsch G; Steiner G; Leeb BF; Dunky A; Bröll H; Smolen JS
J Rheumatol; 1997 Mar; 24(3):518-23. PubMed ID: 9058659
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases.
Cope AP; Aderka D; Doherty M; Engelmann H; Gibbons D; Jones AC; Brennan FM; Maini RN; Wallach D; Feldmann M
Arthritis Rheum; 1992 Oct; 35(10):1160-9. PubMed ID: 1329774
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
[TBL] [Abstract][Full Text] [Related]
8. The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells.
Raychaudhuri SP; Raychaudhuri SK
Scand J Rheumatol; 2009; 38(3):207-15. PubMed ID: 19177265
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis.
Danning CL; Illei GG; Hitchon C; Greer MR; Boumpas DT; McInnes IB
Arthritis Rheum; 2000 Jun; 43(6):1244-56. PubMed ID: 10857783
[TBL] [Abstract][Full Text] [Related]
10. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
11. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of TNF-alpha soluble receptors correlate with outcome in human falciparum malaria.
Deloron P; Roux Lombard P; Ringwald P; Wallon M; Niyongabo T; Aubry P; Dayer JM; Peyron F
Eur Cytokine Netw; 1994; 5(3):331-6. PubMed ID: 7948768
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis.
Fraser A; Fearon U; Reece R; Emery P; Veale DJ
Arthritis Rheum; 2001 Sep; 44(9):2024-8. PubMed ID: 11592363
[TBL] [Abstract][Full Text] [Related]
14. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha.
Alaaeddine N; DiBattista JA; Pelletier JP; Cloutier JM; Kiansa K; Dupuis M; Martel-Pelletier J
J Rheumatol; 1997 Oct; 24(10):1985-94. PubMed ID: 9330943
[TBL] [Abstract][Full Text] [Related]
15. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges A; Gabay C; Silacci P; Novick D; Roux-Lombard P; Grau G; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1997 Aug; 24(8):1510-6. PubMed ID: 9263143
[TBL] [Abstract][Full Text] [Related]
16. [Soluble interleukin 2 receptor (sIL-2R) in chronic polyarthritis].
Herzog C; Herzog A; Aeschlimann A; Gerber H; Müller W
Z Rheumatol; 1990; 49(1):8-10. PubMed ID: 2327181
[TBL] [Abstract][Full Text] [Related]
17. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
[TBL] [Abstract][Full Text] [Related]
18. Synovial fluid induced nuclear factor-kappaB DNA binding in a monocytic cell line.
Lehmann T; Nguyen LQ; Handel ML
J Rheumatol; 2000 Dec; 27(12):2769-76. PubMed ID: 11128662
[TBL] [Abstract][Full Text] [Related]
19. Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis.
Schlenk J; Lorenz HM; Haas JP; Herrmann M; Hohenberger G; Kalden JR; Röllinghoff M; Beuscher HU
J Rheumatol; 2005 Dec; 32(12):2291-8. PubMed ID: 16331752
[TBL] [Abstract][Full Text] [Related]
20. Soluble E-selectin is increased in inflammatory synovial fluid.
Carson CW; Beall LD; Hunder GG; Johnson CM; Newman W
J Rheumatol; 1994 Apr; 21(4):605-11. PubMed ID: 7518520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]